pharma · Nonalcoholic Steatohepatitis (NASH) · Amyotrophic Lateral Sclerosis · CORT
CORCEPT THERAPEUTICS
CORCEPT THERAPEUTICS INC
Corcept Therapeutics is a pharma organization headquartered in Redwood City, USA. It trades on NYSE under ticker CORT. Primary therapeutic focus areas include Nonalcoholic Steatohepatitis (NASH), Amyotrophic Lateral Scle
101 Redwood Shores Pkwy, Redwood City, California 94065, US HQ
1998 Founded
756 Employees
Public company Type
CORT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 101 Redwood Shores Pkwy, Redwood City, California 94065, US
- Founded
- 1998
- Employees
- 756
- Programs
- 67
- Drugs
- 36
- Patents
- 120
Mifepristone
Phase 2 · small molecule · Weight-Gain Prevention
Mifepristone for Weight-Gain Prevention is a Phase 2 program (small_molecule) at CORCEPT THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Internal code C-1073-200
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- CORCEPT THERAPEUTICS INC
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Weight-Gain Prevention
- Status
- completed
- Trials
- 1